基本信息
浏览量:23
职业迁徙
个人简介
Dr. Bellail started her research on ubiquitin posttranslational modification pathways in regulation of cancer cell programed death in human cancer. Her laboratory then demonstrated that the posttranslational pathway of small ubiquitin modifier-1 (SUMO1) drives the cell cycle and cancer progression. In a cancer cell-based drug screening of NCI small molecule laboratory, her team identified the SUMO1 inhibition compound (SMIC1). Her current research aims to develop SMIC1 as a new anticancer drug for clinical cancer therapy and unveil SMIC1 targeted molecular pathways in human cancer.
研究兴趣
论文共 49 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
MOLECULAR CARCINOGENESISno. 9 (2023): 1249-1262
Yin Quan Zhao, Hong Jin,Daeho Kim,Sung Han Jung,Sheng Liu,Jun Wan,Ho‐Yin Lo, Xue Qi Fu, Quan Wang,Chunhai Hao,Anita C. Bellail
Molecular Carcinogenesisno. 9 (2023)
引用0浏览0引用
0
0
Sunghan Jung,Nancy Jaiswal,Ratan K. Rai,Yuichiro Takagi,Ho-Yin Lo, Cen Gao,Lifan Zeng, Xu Wang,Reagan K. Wohlford, Ryan K. Higgins,Anita C. Bellail,Chunhai Hao
biorxiv(2023)
Anita C. Bellail,Hong Ri Jin,Ho-Yin Lo,Sung Han Jung, Chafiq Hamdouchi,Daeho Kim, Ryan K. Higgins,Maximilian Blanck,Carlos le Sage,Benedict C.S. Cross,Jing Li,Amber L. Mosley,Aruna B. Wijeratne,Wen Jiang, Manali Ghosh,Yin Quan Zhao,Paula M. Hauck,Anantha Shekhar,Chunhai Hao
Chunhai Hao,Anita C. Bellail
Encyclopedia of Cancerpp.608-614, (2017)
Canadian journal of neurological sciencesno. S2 (2015): S2-S2
加载更多
作者统计
#Papers: 48
#Citation: 3166
H-Index: 19
G-Index: 48
Sociability: 5
Diversity: 0
Activity: 0
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn